ArticleCancers2022

Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS).

Sojung Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.